Analysen von Peter Welford
| 04.02.19 | Roche buy | Jefferies & Company Inc. | |
| 31.01.19 | GSK buy | Jefferies & Company Inc. | |
| 31.01.19 | Roche buy | Jefferies & Company Inc. | |
| 30.01.19 | Novartis buy | Jefferies & Company Inc. | |
| 11.12.18 | Roche buy | Jefferies & Company Inc. | |
| 11.12.18 | GSK buy | Jefferies & Company Inc. | |
| 11.12.18 | Sanofi buy | Jefferies & Company Inc. | 
 
                                